IP Library › Granted Patent US 8,461,351
Granted Patent B2
US 8,461,351 · App. 13/193,326 · Granted Jun 11, 2013

Sterically bulky stabilizers

Inventors: Rina Carlini (Oakville, CA); Darren Andrew Makeiff (St. Alberta, CA)
Assignees: Xerox Corporation; National Research Council of Canada
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,461,351
App. No.
13/193,326
Granted
Jun 11, 2013
Kind
B2
Abstract

A sterically bulky stabilizer that includes an alkylated-benzimidazolone compound, where the sterically bulky stabilizer is associated non-covalently with a benzimidazolone pigment, and the presence of the sterically bulky stabilizer limits the extent of particle growth and aggregation, to afford nanoscale pigment particles.

Claims (121)

1. A sterically bulky stabilizer of the formula:

wherein each of R a and R b independently represent H or substituted or unsubstituted alkyl groups, provided that at least one of R a and R b on each benzimidazolone group represents H, and R c represents a group selected from the group consisting of:

—X—(CH 2 ) n X—; —[(XCH 2 CH 2 ) n ]X—; —[(C═O)—(CH 2 ) n — (C═O)]—; —X—[(C═O)—(CH 2 ) n —(C═O)]—X—; —X—[(C═O)—X—(CH 2 ) n —X—(C═O)]—X—; —[(C═O)—X—(CH 2 ) n —X—(C═O)]—;

wherein X, X 1 , and X 2 independently represent O, S, or NH, and n is an integer of 1 to 50.

2. The sterically bulky stabilizer of claim 1 , wherein the sterically bulky stabilizer compound comprises an alkylated-benzimidazolone selected from the group consisting of the following compounds:

Group X

R 1

R 2

R 3

X 1 = X 2 = NH

H

H

X 1 = O X 2 = NH

H

H

X 1 = NH

H

H

X 1 = O

H

H

X 1 = O

H

H

X 1 = NH

H

H

3. A sterically bulky stabilizer comprising an alkylated-benzimidazolone selected from the group consisting of the following compounds:

Position 5

functional

Sterically Bulky Group(s)

moiety

X

R 1

R 2

R 3

NH

(CH 2 ) n CH 3 n = 2, 11, 17

—

—

NH

—

—

NH

—

—

NH

—

—

X 1 = X 2 = NH

(CH 2 ) n CH 3 n = 11, 17

—

—

X 1 = O X 2 = NH

(CH 2 ) n CH 3 n = 11, 17

—

—

N

H

(CH 2 ) n CH 3 n = 1, 17

—

N

H

—

N

(CH 2 ) n CH 3 n = 3, 11, 17

(CH 2 ) n CH 3 n = 3, 11, 17

—

N

—

N

—

N

(CH 2 ) n CH 3 n = 1, 17

(CH 2 ) n CH 3 n = 1, 17

(CH 2 ) n CH 3 n = 1, 17

N

N

Position 5

functional

moiety

R 1

R 2

R 3

X 1 = X 2 = NH

H

H

X 1 = O X 2 = NH

H

H

X 1 = NH

H

H

X 1 = O

H

H

X 1 = O

H

H

X 1 = NH

H

H

—

H

—(CH 2 ) n CH 3 n = 1, 17

—

—

—(CH 2 ) n CH 3 n = 1, 17

H

—

—

H

H

—

—

H

H

—

Group X

R c

wherein DC n represents a diazo moiety.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073562/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2017
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: XEROX CORPORATION
Reel/Frame 042195/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2013
From: CARLINI, RINA; MARKEIFF, DARREN ANDREW
To: XEROX CORPORATION; NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 030316/0050 →
Continuity (6)
Continuation 12853536 · Aug 10, 2010
Continuation In Part 12581488 · Oct 19, 2009
Continuation In Part 12509161 · Jul 24, 2009
Continuation In Part 12405079 · Mar 16, 2009
Continuation 12044613 · Mar 7, 2008
Related Publication 20110303122A1 · Dec 15, 2011